How Much of Futibatinib for Daily Cholangiocarcinoma Treatment?

Futibatinib is a drug made for treating cholangiocarcinoma, a kind of liver cancer, and it’s used for people who have mutations in the FGFR2 gene. Futibatinib is part of a group of drugs called FGFR inhibitors. They work by stopping the FGFR signaling pathway.

You can get Futibatinib in 4 mg tablet form. Doctors usually suggest taking 20 mg of Futibatinib once a day. A usual bottle of Futibatinib has 28 tablets.

Since it’s an FGFR inhibitor, Futibatinib is mainly used for people with FGFR2 fusions, giving them a focused treatment for cholangiocarcinoma that has this gene change.